UNC Scientists Take a Big Step toward a Better Opioid

January 10, 2018

For the first time, scientists at the University of North Carolina at Chapel Hill and collaborators solved the crystal structure of the activated kappa opioid receptor bound to a morphine derivative. They then created a new drug-like compound that activates only that … Continued

Bowers Receives $1.9 M NIGMS Outstanding Investigator Award

December 7, 2017

Albert Bowers, Ph.D., has received a R35 Outstanding Investigator Award worth more than $1.9 million over five years from the National Institute of General Medical Sciences to study the chemoenzymatic synthesis, mode of action and evolution of natural product-based macrocycles. … Continued

PharmAlliance Conferences Bring Pharmacy World to Chapel Hill

November 21, 2017

The members of PharmAlliance gathered in Chapel Hill Nov. 15 to 19 as the UNC Eshelman School of Pharmacy hosted researchers and educators from Monash University in Melbourne, Australia, and University College London in the United Kingdom for a five-day, … Continued

Cao Receives R35 Outstanding Investigator Grant

November 16, 2017

Yanguang “Carter” Cao, Ph.D., has received an R35 Outstanding Investigator Grant worth $1.85 million over five years from the National Institute of General Medical Sciences to create a platform to optimize antibody-based therapy. “Therapeutic antibodies have achieved great success in … Continued

UNC Catalyst Hosts NIH/NCATS Assay Guidance Workshop

October 25, 2017

UNC Catalyst Hosts NIH/NCATS Assay Guidance Workshop The UNC Catalyst for Rare Diseases, together with Promega, sponsored an NIH/NCATS assay guidance workshop for high-throughput screening and lead discovery on Monday, October 23. Forty-nine scientists from academia and the pharmaceutical and … Continued